HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Drug-induced motor complications in dopa-responsive dystonia: implications for the pathogenesis of dyskinesias and motor fluctuations.

Abstract
Dopa-responsive dystonia (DRD) is characterized by striatal dopamine depletion with preserved nigrostriatal terminals. Patients with DRD typically obtain a marked long-term benefit from low doses of levodopa, with no motor complications. By contrast, motor fluctuations and dyskinesias often occur in idiopathic parkinsonism (Parkinson's disease; PD). This suggests that nigrostriatal denervation may be necessary for the development of these levodopa-related motor complications. Six genetically confirmed DRD cases were studied. Three of the five patients who were on chronic levodopa therapy developed choreic dyskinesias, which disappeared on reduction of medication. Apomorphine also induced dyskinesias. In addition, two patients experienced acute dystonic reactions after exposure to dopamine receptor-blocking drugs. No patient showed dose-response motor flutuations during levodopa treatment. It is proposed that striatal dopamine deficiency might play a major role in the pathogenesis of drug-induced dyskinesias. Conversely, the loss of nigrostriatal dopamine terminals seems to be a prerequisite for the development of levodopa-related motor fluctuations.
AuthorsR de la Fuente-Fernández
JournalClinical neuropharmacology (Clin Neuropharmacol) 1999 Jul-Aug Vol. 22 Issue 4 Pg. 216-9 ISSN: 0362-5664 [Print] UNITED STATES
PMID10442251 (Publication Type: Journal Article)
Chemical References
  • Dopamine Agents
  • Levodopa
  • GTP Cyclohydrolase
  • Carbidopa
Topics
  • Adolescent
  • Adult
  • Aged
  • Carbidopa (therapeutic use)
  • Dopamine Agents (adverse effects, therapeutic use)
  • Dyskinesia, Drug-Induced
  • Dystonia (drug therapy, genetics)
  • Female
  • GTP Cyclohydrolase (genetics)
  • Humans
  • Levodopa (adverse effects, therapeutic use)
  • Male
  • Middle Aged
  • Motor Skills Disorders (chemically induced, etiology)
  • Parkinson Disease (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: